Your browser doesn't support javascript.
Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients.
Patel, K; Gooley, T A; Bailey, N; Bailey, M; Hegerova, L; Batchelder, A; Holdread, H; Dunleavy, V; Downey, T; Frisvold, J; Megrath, S; Pagarigan, K; Szeto, J; Rueda, J; Islam, A; Maree, C; Nyatsatsang, S; Bork, S E; Lipke, A; O'Mahony, D S; Wagner, T; Pulido, J; Mignone, J; Youssef, S; Hartman, M; Goldman, J D; Pagel, J M.
  • Patel K; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Bailey N; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Bailey M; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Hegerova L; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Batchelder A; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Holdread H; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Dunleavy V; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Downey T; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Frisvold J; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Megrath S; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Pagarigan K; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Szeto J; From the Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA.
  • Rueda J; Infectious Disease, Swedish Medical Center, Seattle, WA, USA.
  • Islam A; Infectious Disease, Swedish Medical Center, Seattle, WA, USA.
  • Maree C; Infectious Disease, Swedish Medical Center, Seattle, WA, USA.
  • Nyatsatsang S; Infectious Disease, Swedish Medical Center, Seattle, WA, USA.
  • Bork SE; Hospital Medicine, Swedish Medical Center, Seattle, WA, USA.
  • Lipke A; Pulmonary and Critical Care, Swedish Medical Center, Seattle, WA, USA.
  • O'Mahony DS; Pulmonary and Critical Care, Swedish Medical Center, Seattle, WA, USA.
  • Wagner T; Pulmonary and Critical Care, Swedish Medical Center, Seattle, WA, USA.
  • Pulido J; US Anesthesia Partners, Seattle, WA, USA.
  • Mignone J; Swedish Heart and Vascular Institute, Swedish Medical Center, Seattle, WA, USA.
  • Youssef S; Swedish Heart and Vascular Institute, Swedish Medical Center, Seattle, WA, USA.
  • Hartman M; Swedish Heart and Vascular Institute, Swedish Medical Center, Seattle, WA, USA.
  • Goldman JD; Swedish Heart and Vascular Institute, Swedish Medical Center, Seattle, WA, USA.
  • Pagel JM; Infectious Disease, Swedish Medical Center, Seattle, WA, USA.
J Intern Med ; 289(3): 430-433, 2021 03.
Article in English | MEDLINE | ID: covidwho-692473

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Observational study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: J Intern Med Journal subject: Internal Medicine Year: 2021 Document Type: Article Affiliation country: Joim.13163

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Observational study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: J Intern Med Journal subject: Internal Medicine Year: 2021 Document Type: Article Affiliation country: Joim.13163